MAGGI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 8.429
AS - Asia 8.357
NA - Nord America 2.786
SA - Sud America 1.320
AF - Africa 89
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.987
Nazione #
RU - Federazione Russa 4.815
SG - Singapore 2.930
US - Stati Uniti d'America 2.693
IE - Irlanda 2.259
CN - Cina 2.173
HK - Hong Kong 1.602
BR - Brasile 1.136
IT - Italia 600
KR - Corea 483
IN - India 434
VN - Vietnam 327
GB - Regno Unito 181
JP - Giappone 168
DE - Germania 165
AR - Argentina 88
FR - Francia 83
BD - Bangladesh 46
AT - Austria 45
NL - Olanda 42
FI - Finlandia 41
UA - Ucraina 39
GR - Grecia 38
MX - Messico 34
CZ - Repubblica Ceca 33
ID - Indonesia 29
IQ - Iraq 29
CA - Canada 27
CO - Colombia 24
TR - Turchia 24
EC - Ecuador 23
SE - Svezia 23
MA - Marocco 21
ZA - Sudafrica 19
PY - Paraguay 15
VE - Venezuela 14
AE - Emirati Arabi Uniti 13
PL - Polonia 13
AZ - Azerbaigian 12
KE - Kenya 11
PK - Pakistan 11
UY - Uruguay 11
ES - Italia 10
MY - Malesia 9
TN - Tunisia 9
UZ - Uzbekistan 9
BE - Belgio 8
SA - Arabia Saudita 7
ET - Etiopia 6
HN - Honduras 6
IL - Israele 6
KZ - Kazakistan 6
LB - Libano 6
LT - Lituania 6
NP - Nepal 6
PH - Filippine 6
TT - Trinidad e Tobago 6
AU - Australia 5
DZ - Algeria 5
JO - Giordania 5
AL - Albania 4
BG - Bulgaria 4
CM - Camerun 4
PE - Perù 4
PT - Portogallo 4
BH - Bahrain 3
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
KW - Kuwait 3
PA - Panama 3
SY - Repubblica araba siriana 3
BO - Bolivia 2
BY - Bielorussia 2
CD - Congo 2
CG - Congo 2
EG - Egitto 2
ML - Mali 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
SI - Slovenia 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
EU - Europa 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
NG - Nigeria 1
PR - Porto Rico 1
Totale 20.984
Città #
Dublin 2.258
Hong Kong 1.602
Moscow 1.487
Santa Clara 930
Hefei 875
Singapore 736
Seoul 483
Bengaluru 350
Boardman 142
The Dalles 139
Chandler 135
Ho Chi Minh City 123
New York 108
Ashburn 107
São Paulo 95
Jacksonville 86
Hanoi 76
Princeton 75
Roxbury 74
Dallas 70
Naples 63
Cambridge 49
Los Angeles 45
Beijing 41
Falkenstein 41
Pune 41
Brasília 35
Rio de Janeiro 32
Amsterdam 31
Bremen 31
Medford 30
Nuremberg 29
Brno 27
Ann Arbor 26
Belo Horizonte 26
Munich 26
Jinan 24
Vienna 23
Caserta 22
Des Moines 22
Helsinki 19
Curitiba 18
Guangzhou 18
Wilmington 18
Dhaka 16
Haiphong 16
Istanbul 15
Milan 15
Napoli 15
Salvador 15
Changsha 14
Shenzhen 14
Toronto 14
Turku 14
Bari 13
Brooklyn 13
Porto Alegre 13
Zhengzhou 13
Buenos Aires 12
Casablanca 12
Da Nang 12
Fortaleza 12
Hangzhou 12
Rome 12
San Francisco 12
Tianjin 12
Baku 11
Palermo 11
Warsaw 11
Biên Hòa 10
Carapicuíba 10
Charlotte 10
Frankfurt am Main 10
Hebei 10
Thái Bình 10
Asunción 9
Baghdad 9
Bogotá 9
Chicago 9
Goiânia 9
Guarulhos 9
Guayaquil 9
Johannesburg 9
Kuala Lumpur 9
Manaus 9
Messina 9
Montevideo 9
Santo André 9
Shenyang 9
Tashkent 9
Brussels 8
Campinas 8
Duque de Caxias 8
Nairobi 8
Paris 8
Quito 8
Redwood City 8
Sorocaba 8
Stockholm 8
Xi'an 8
Totale 11.292
Nome #
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 132
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 124
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 122
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 121
[Acquired immunodeficiency syndrome and pulmonary Mycobacterium xenopi infection. Role of computerized tomography] 112
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 107
Hyperglycaemia on admission to hospital and COVID-19 105
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 99
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 98
Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model 97
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 96
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 94
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 94
A comprehensive development agenda on tenofovir alafenamide in clinical practice 88
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 87
Implications of AB0 blood group in hypertensive patients with covid-19 87
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 86
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 86
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 85
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 83
. Prevaleat study (Premature Vascular Lesions and Antiretroviral Therapy). A comparative study between patients treated with PI-including regimens vs NNRTI-including regimens 83
Alexithymia is linked to neurocognitive function independently of sociodemographic and clinical predictors. A multicentric HIV cohort study 83
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study 83
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 82
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 81
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 80
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 80
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study 80
Weight gain in dolutegravir containing regimens in the observational SCOLTA cohort. 79
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 79
Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study 79
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 78
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy 78
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 77
Evaluation of lipid profile in HIV naive patients, treated by TAF-based regimens. 77
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 77
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 76
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 76
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 76
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study. 76
Archi-Prevaleat project. A National Register of color-Doppler ultrasonography of the epi-aortic vessels in Patients Living with HIV. 75
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. 74
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 74
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 73
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 73
Occupational risk linked to leptospirae in Apulia 73
Squillace N, Menzaghi B, Migliorino GM, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò G, Bonfanti P. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide and cholesterol increase: impact on cardiovascular risk assessment. Journal of HIV and Ageing. 73
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 72
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 72
Primary prophylaxis against pneumocystis carinii and Toxoplasma gondii with low dose cotrimoxazole: a case-control study 71
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 71
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 71
A case of human brucellosis caused by accidental injection of animal vaccine 71
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 71
Dolutegravir safety in a real-life setting: results Title from the SCOLTA cohort 71
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 69
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 69
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 67
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 67
Ruolo della diagnostica con Fibroscan nella valutazione della fibrosi epatica in pazienti HIV-positivi. Confronto tra soggetti monoinfetti versus coinfetti 67
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 67
HIV Effectiveness Italian Conference; HEFFICON Study Group 66
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 66
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 66
Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis 66
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 66
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 65
Abnormalities of abdominal wall: a case of venous displasia between external mammary common femoral veins and right iliac axis with varicocele 65
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 65
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 65
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 65
Cardiovascular risk assessment in antiretroviral-naive patients 64
Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Prevalence of Human Immunodeficiency virus, Hepatitis B Virus and Hepatitis C Virus among dialysis patients. 64
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 64
Incident diabetes in course of antiretroviral therapy 64
HCV infection occupational hazard at dialysis units and virus spread among relatives of dialyzed patients 64
Smoking habits in HIV-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort 64
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 64
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV? 64
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 63
Safety and metabolic impact of darunaviur/cobicistat in a real-life setting. Results from the SCOLTA study cohort. 63
Isolamento dell' HIV e antigenemia P24 62
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 62
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 62
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 62
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? 62
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study). 62
Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients 61
Factors associated with hospital admission for COVID-19 in HIV patients. 61
Leishmaniosi viscerale e infezione da HIV in Puglia. 59
Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection 59
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience 59
Precocious lesions of the carotid vessels in HIV-1 patients treated with protease inhibitors 58
Early markers of mitochondrial tubular injury in patients treated with tenofovir vs abacavir-including backbones. 58
Le malattie infettive nelle grandi catastrofi 58
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 58
Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents. 57
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection 57
Movement disorders in patients with cerebral toxoplasmosis and AIDS 56
Citrati urinari ed escrezione di glucosaminoglicani in soggetti sani ed in pazienti con nefrolitiasi ossalocalcica recidivante 55
Totale 7.495
Categoria #
all - tutte 91.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 33 35 32 8 39 38 7
2021/2022446 6 16 4 7 145 9 19 11 22 17 25 165
2022/20232.335 100 17 10 12 100 39 320 45 1.654 10 10 18
2023/20241.638 29 55 45 164 695 170 23 11 15 17 108 306
2024/20255.448 18 31 9 209 929 172 880 545 843 987 399 426
2025/202611.000 794 1.815 1.560 1.123 1.471 4.237 0 0 0 0 0 0
Totale 21.466